Sweeney Edward J 4

Accession 0001209191-11-016053

CIK 0001100962other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 6:53 PM ET

Size

42.4 KB

Accession

0001209191-11-016053

Insider Transaction Report

Form 4

Period: 2011-03-03

ENDO PHARMACEUTICALS HOLDINGS INCENDP

Sweeney Edward J

Principal Accounting Officer

Transactions

Sale
Common Stock, par value, $0.01 per share
2011-03-03$36.00/sh−5,068$182,448→ 0 total
Exercise/Conversion
Common Stock, par value, $.01 per share
2011-03-03$16.47/sh+1,292$21,279→ 1,292 total
Exercise/Conversion
Common Stock, par value, $.01 per share
2011-03-03$28.61/sh+6,339$181,359→ 6,339 total
Exercise/Conversion
Common Stock, par value, $0.01 per share
2011-03-03$25.19/sh+5,068$127,663→ 5,068 total
Sale
Common Stock, par value, $.01 per share
2011-03-03$36.00/sh−1,292$46,512→ 0 total
Sale
Common Stock, par value, $0.01 per share
2011-03-03$36.25/sh−6,339$229,789→ 0 total
Exercise/Conversion
Common Stock, par value, $0.01 per share
2011-03-03$30.55/sh+4,612$140,897→ 4,612 total
Sale
Common Stock, par value, $0.01 per share
2011-03-03$36.25/sh−4,612$167,185→ 0 total
Exercise/Conversion
Common Stock, par value, $0.01 per share
2011-03-03$19.93/sh+5,760$114,797→ 5,760 total
Sale
Common Stock, par value, $0.01 per share
2011-03-03$36.00/sh−3,319$119,484→ 0 total
Exercise/Conversion
2004 Stock Incentive Plan Options
2011-03-03−6,339→ 0 total
Exercise: $28.61Exp: 2016-02-14→ Common Stock (6,339 underlying)
Exercise/Conversion
2007 Stock Incentive Plan Options
2011-03-03−5,068→ 1,689 total
Exercise: $25.19Exp: 2018-02-21→ Common Stock (5,068 underlying)
Exercise/Conversion
2007 Stock Incentive Plan Options
2011-03-03−3,319→ 9,957 total
Exercise: $20.61Exp: 2020-02-19→ Common Stock (3,319 underlying)
Sale
Common Stock, par value, $0.01 per share
2011-03-03$36.00/sh−5,760$207,360→ 0 total
Exercise/Conversion
Common Stock, par value, $0.01 per share
2011-03-03$20.61/sh+3,319$68,405→ 3,319 total
Exercise/Conversion
2000 Stock Incentive Plan Options
2011-03-03−1,292→ 0 total
Exercise: $16.47Exp: 2014-08-11→ Common Stock (1,292 underlying)
Exercise/Conversion
2000 Stock Incentive Plan Options
2011-03-03−4,612→ 0 total
Exercise: $30.55Exp: 2017-02-21→ Common Stock (4,612 underlying)
Exercise/Conversion
2007 Stock Incentive Plan Options
2011-03-03−5,760→ 5,760 total
Exercise: $19.93Exp: 2019-02-26→ Common Stock (5,760 underlying)

Footnotes (8)

[F1]This represents the average price that Mr. Sweeney's common shares were sold at on March 3, 2011.
[F2]Mr. Sweeney's stock options that were granted under the 2000 Stock Incentive Plan on August 11, 2004 were exercisable 25% per year on each of August 11, 2005, August 11, 2006, August 11, 2007 and August 11, 2008. The 1,292 stock options that were exercised now are those that remained exercisable from Mr. Sweeney's original grant of 2,586 stock options.
[F3]These securities were granted to Mr. Sweeney in consideration of his services as the Principal Accounting Officer of Endo Pharmaceuticals Holdings Inc.
[F4]Mr. Sweeney's stock options that were granted under the 2004 Stock Incentive Plan on February 14, 2006 were exercisable 25% per year on each of February 14, 2007, February 14, 2008, February 14, 2009 and February 14, 2010. The 6,339 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 6,339 stock options.
[F5]Mr. Sweeney's stock options that were granted under the 2000 Stock Incentive Plan on February 21, 2007 were exercisable 25% per year on each of February 21, 2008, February 21, 2009, February 21, 2010 and February 21, 2011. The 4,612 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 4,612 stock options, including those that became exercisable on February 21, 2011.
[F6]Mr. Sweeney's stock options that were granted under the 2007 Stock Incentive Plan on February 21, 2008 are generally exercisable 25% per year on each of February 21, 2009, February 21, 2010, February 21, 2011 and February 21, 2012. The 5,068 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 6,757 stock options, including those that became exercisable on February 21, 2011.
[F7]Mr. Sweeney's stock options that were granted under the 2007 Stock Incentive Plan on February 26, 2009 are generally exercisable 25% per year on each of February 26, 2010, February 26, 2011, February 26, 2012 and February 26, 2013. The 5,760 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 11,520 stock options, including those that became exercisable on February 26, 2011.
[F8]Mr. Sweeney's stock options that were granted under the 2007 Stock Incentive Plan on February 19, 2010 are generally exercisable 25% per year on each of February 19, 2011, February 19, 2012, February 19, 2013 and February 19, 2014. The 3,319 stock options that were exercised now represent all of the shares exercisable from Mr. Sweeney's original grant of 13,276 stock options and are those shares that became exercisable on February 19, 2011.

Documents

2 files

Issuer

ENDO PHARMACEUTICALS HOLDINGS INC

CIK 0001100962

→

Entity typeother

Related Parties

filerCIK 0001455549

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 6:53 PM ET
Size: 42.4 KB

View on SEC.gov